Livsmed Inc (KOSDAQ:491000)

Livsmed Statistics

Total Valuation

Livsmed has a market cap or net worth of KRW 1.61 trillion. The enterprise value is 1.49 trillion.

Market Cap	1.61T
Enterprise Value	1.49T

Important Dates

The next estimated earnings date is Tuesday, April 14, 2026.

Earnings Date	Apr 14, 2026
Ex-Dividend Date	n/a

Share Statistics

Livsmed has 24.95 million shares outstanding. The number of shares has increased by 32.88% in one year.

Current Share Class	24.95M
Shares Outstanding	24.95M
Shares Change (YoY)	+32.88%
Shares Change (QoQ)	+1.77%
Owned by Insiders (%)	39.07%
Owned by Institutions (%)	13.12%
Float	14.98M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	31.49
PB Ratio	8.91
P/TBV Ratio	9.00
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-65.24
EV / Sales	29.15
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-35.55

Financial Position

The company has a current ratio of 12.68, with a Debt / Equity ratio of 0.06.

Current Ratio	12.68
Quick Ratio	11.82
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	-0.28
Interest Coverage	-27.53

Financial Efficiency

Return on equity (ROE) is -20.75% and return on invested capital (ROIC) is -11.77%.

Return on Equity (ROE)	-20.75%
Return on Assets (ROA)	-11.09%
Return on Invested Capital (ROIC)	-11.77%
Return on Capital Employed (ROCE)	-12.03%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.40
Inventory Turnover	3.08

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	78,294.00
200-Day Moving Average	n/a
Relative Strength Index (RSI)	41.69
Average Volume (20 Days)	353,287

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Livsmed had revenue of KRW 51.19 billion and -22.87 billion in losses. Loss per share was -1,030.07.

Revenue	51.19B
Gross Profit	29.53B
Operating Income	-22.64B
Pretax Income	-22.87B
Net Income	-22.87B
EBITDA	-19.91B
EBIT	-22.64B
Loss Per Share	-1,030.07

Balance Sheet

The company has 131.40 billion in cash and 11.61 billion in debt, with a net cash position of 119.79 billion or 4,800.74 per share.

Cash & Cash Equivalents	131.40B
Total Debt	11.61B
Net Cash	119.79B
Net Cash Per Share	4,800.74
Equity (Book Value)	180.87B
Book Value Per Share	7,328.07
Working Capital	161.06B

Cash Flow

In the last 12 months, operating cash flow was -34.74 billion and capital expenditures -7.23 billion, giving a free cash flow of -41.97 billion.

Operating Cash Flow	-34.74B
Capital Expenditures	-7.23B
Depreciation & Amortization	2.73B
Net Borrowing	-672.35M
Free Cash Flow	-41.97B
FCF Per Share	-1,682.07

Margins

Gross margin is 57.69%, with operating and profit margins of -44.23% and -44.68%.

Gross Margin	57.69%
Operating Margin	-44.23%
Pretax Margin	-44.68%
Profit Margin	-44.68%
EBITDA Margin	-38.89%
EBIT Margin	-44.23%
FCF Margin	n/a

Dividends & Yields

Livsmed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-32.88%
Shareholder Yield	-32.88%
Earnings Yield	-1.42%
FCF Yield	-2.60%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Livsmed has an Altman Z-Score of 33.46 and a Piotroski F-Score of 2.

Altman Z-Score	33.46
Piotroski F-Score	2